Negative sentiment amongst healthcare professionals about the impact of Brexit on the UK healthcare sector has increased over the last 3 months, according to GlobalData, a leading data and analytics company.
GlobalData’s latest report, ‘Brexit and the Healthcare Industry – Implications for Pharma, Q3 2018’, reveals that 59% of healthcare industry professionals now have a negative sentiment about Brexit’s impact on the UK healthcare sector, compared to only 42% who expressed the same opinion in June 2018. Healthcare professionals from the US, UK and EU took part in the survey with respondents from the EU expressing the biggest fall in Brexit confidence, with a 28% increase in negative sentiment since the previous survey.
Click here to READ MORE
The report is based on a quarterly survey of participants from the pharmaceutical industry, both within and outside the UK, who were asked about the impact of Brexit on the healthcare sector as well as their evolving sentiment towards Brexit.
Alexandra Annis, MS, Managing Healthcare Analyst at GlobalData, commented, “One potential explanation for the increase in negative sentiment in Q3 is less clarity over the future of Brexit, especially in the EU. The Brexit process has a long way to go and is filled with uncertainty as a ‘no deal’ Brexit becomes an increasing possibility.’’